SLYG - ETF AI Analysis
Top Page
SPDR S&P 600 Small Cap Growth ETF (SLYG)
Rating:69Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and in recent months, indicating solid recent momentum.
Broad Sector Diversification
Holdings are spread across many sectors, including industrials, technology, health care, and financials, which helps reduce the impact of weakness in any single industry.
Low Expense Ratio
The fund’s relatively low annual fee means less of your return is eaten up by costs over time.
Negative Factors
Heavy U.S. Concentration
Almost all of the ETF’s assets are invested in U.S. companies, offering little geographic diversification.
Small-Cap Growth Volatility
Because it focuses on small, fast-growing companies, the fund can be more sensitive to market swings than large-cap or value-focused ETFs.
Mixed Performance Among Top Holdings
While many top positions have delivered strong gains, at least one key holding has been weak this year, which can drag on overall results.
SLYG vs. SPDR S&P 500 ETF (SPY)
AUM5.15B
RegionNorth America
Expense Ratio0.15%
Beta0.95
IssuerSPDR
Inception DateSep 25, 2000
Dividend Yield0.65%
Asset ClassEquity
Index TrackedS&P Small Cap 600 Growth
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume162,702
30 Day Avg. Volume158,761
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
132.45Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering347
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SLYG Summary
SLYG is an ETF that follows the S&P SmallCap 600 Growth Index, which focuses on smaller U.S. companies expected to grow quickly. It holds a wide mix of industries, including technology, industrials, and health care, with examples like FormFactor and Viavi Solutions. Investors might consider SLYG if they want growth potential from up‑and‑coming businesses and diversification across many small companies instead of picking individual stocks. However, small-cap growth stocks can be more volatile than larger, more established companies, so the price of this ETF can go up and down sharply with market conditions.
How much will it cost me?The SPDR S&P 600 Small Cap Growth ETF (SLYG) has an expense ratio of 0.15%, meaning you’ll pay $1.50 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking the S&P SmallCap 600 Growth Index rather than relying on active stock picking.
What would affect this ETF?SLYG could benefit from a strong U.S. economy, as its focus on small-cap growth companies in sectors like Industrials and Technology aligns with innovation and infrastructure trends. However, rising interest rates or economic slowdowns may negatively impact small-cap stocks, which are often more sensitive to borrowing costs and market volatility. Regulatory changes or sector-specific challenges in areas like Health Care or Financials could also influence the ETF's performance.
SLYG Top 10 Holdings
SLYG is leaning into a classic small-cap growth story, with industrial and health care names doing much of the heavy lifting. Powell Industries and Argan have been rising steadily on strong backlogs and power-sector demand, giving the fund a solid industrial backbone. In health care, Alkermes and Krystal Biotech add some biotech flair, with generally upbeat momentum, though valuations look rich and could lose a bit of steam. FormFactor and ViaSat bring a tech tilt; FormFactor is climbing, while ViaSat’s mixed, leverage-heavy profile can occasionally drag on performance. Overall, it’s a U.S.-focused, diversified small-cap growth play, but with clear clusters in industrials, health care, and niche tech.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ViaSat | 1.25% | $64.21M | $11.34B | 426.05% | 56 Neutral | |
| BrightSpring Health Services, Inc. | 1.21% | $62.13M | $13.55B | 229.10% | 67 Neutral | |
| Argan | 1.09% | $56.10M | $9.90B | 227.45% | 73 Outperform | |
| Krystal Biotech | 1.09% | $55.98M | $11.06B | 157.16% | 80 Outperform | |
| Formfactor | 1.07% | $54.84M | $9.63B | 196.15% | 68 Neutral | |
| Alkermes | 1.01% | $51.98M | $9.10B | 87.95% | 80 Outperform | |
| Corcept Therapeutics | 0.96% | $49.23M | $9.68B | 37.97% | 76 Outperform | |
| Esco Technologies | 0.95% | $49.05M | $8.62B | 77.64% | 70 Neutral | |
| StoneX Group | 0.94% | $48.36M | $9.55B | 89.91% | 58 Neutral | |
| Ryman | 0.90% | $46.21M | $8.07B | 25.14% | 66 Neutral |
SLYG Technical Analysis
Positive
―
Price Trends
110.59
Positive
105.26
Positive
100.33
Positive
Market Momentum
2.19
Positive
55.26
Neutral
44.91
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SLYG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 114.75, equal to the 50-day MA of 110.59, and equal to the 200-day MA of 100.33, indicating a bullish trend. The MACD of 2.19 indicates Positive momentum. The RSI at 55.26 is Neutral, neither overbought nor oversold. The STOCH value of 44.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SLYG.
SLYG Peer Comparison
Comparison Results
Performance Comparison
SLYG
SPDR S&P 600 Small Cap Growth ETF
115.30
24.50
26.98%
FNDA
Schwab Fundamental US Small Co. Index ETF
―
―
―
IJT
iShares S&P Small-Cap 600 Growth ETF
―
―
―
VTWG
Vanguard Russell 2000 Growth ETF
―
―
―
FYC
First Trust Small Cap Growth AlphaDEX Fund
―
―
―
VIOG
Vanguard S&P Small-Cap 600 Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents